APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 213 filers reported holding APELLIS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $4,695,033 | -46.7% | 71,180 | -58.2% | 0.41% | -41.8% |
| Q4 2022 | $8,808,954 | -0.5% | 170,353 | +31.5% | 0.70% | -6.3% |
| Q3 2022 | $8,850,000 | +0.3% | 129,577 | -33.6% | 0.75% | +0.5% |
| Q2 2022 | $8,824,000 | -21.5% | 195,126 | -11.8% | 0.75% | -15.3% |
| Q1 2022 | $11,242,000 | -43.9% | 221,251 | -47.8% | 0.88% | -31.0% |
| Q4 2021 | $20,031,000 | +194.0% | 423,676 | +104.9% | 1.28% | +202.4% |
| Q3 2021 | $6,814,000 | -72.7% | 206,746 | -47.7% | 0.42% | -66.6% |
| Q2 2021 | $24,966,000 | +53.4% | 395,033 | +4.1% | 1.27% | +17.2% |
| Q1 2021 | $16,280,000 | – | 379,395 | – | 1.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 2,503,059 | $170,959,000 | 29.50% |
| ACUTA CAPITAL PARTNERS, LLC | 554,000 | $37,838,000 | 16.29% |
| Avoro Capital Advisors LLC | 10,125,000 | $691,538,000 | 12.78% |
| Sio Capital Management, LLC | 507,700 | $34,676,000 | 11.02% |
| Logos Global Management LP | 1,300,000 | $88,790,000 | 10.92% |
| EcoR1 Capital, LLC | 5,183,431 | $354,028,000 | 10.45% |
| Cormorant Asset Management, LP | 1,478,000 | $100,947,000 | 7.06% |
| Finepoint Capital LP | 266,090 | $18,174,000 | 5.98% |
| Ghost Tree Capital, LLC | 275,000 | $18,783,000 | 5.27% |
| Boxer Capital, LLC | 1,303,700 | $89,043,000 | 5.01% |